Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis (Q36123904)

12 August 2017

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis (English)

1 reference

Nonalcoholic Steatohepatitis Clinical Research Network

12 August 2017

0 references

8

object named as

Nonalcoholic Steatohepatitis Clinical Research Network

1 reference

12 August 2017

5

Joel Lavine

1 reference

12 August 2017

Rohit Loomba

1

1 reference

12 August 2017

Maria Abraham

2

1 reference

12 August 2017

Aynur Unalp

3

1 reference

12 August 2017

Laura Wilson

4

1 reference

12 August 2017

Ed Doo

6

1 reference

12 August 2017

Nathan M Bass

7

1 reference

12 August 2017

language of work or name

English

0 references

publication date

26 July 2012

1 reference

12 August 2017

1 reference

12 August 2017

56

1 reference

12 August 2017

943-951

1 reference

12 August 2017

3

1 reference

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Genetic covariance between gamma-glutamyl transpeptidase and fatty liver risk factors: role of beta2-adrenergic receptor genetic variation in twins

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

National Institutes of Health State-of-the-Science Conference Statement: Family History and Improving Health

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Parental obesity and offspring serum alanine and aspartate aminotransferase levels: the Framingham heart study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

First-degree relatives of patients with type 2 diabetes mellitus and risk of non-alcoholic Fatty liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Genetic influences in nonalcoholic fatty liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

The potential role of genes in nonalcoholic fatty liver disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

The natural history of nonalcoholic fatty liver disease: a clinical histopathological study

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

The prevalence and etiology of elevated aminotransferase levels in the United States

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

Association of nonalcoholic fatty liver disease with insulin resistance.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3407289

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22505194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22505194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Familial aggregation of insulin resistance in first-degree relatives of patients with nonalcoholic fatty liver disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22505194

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/HEP.25772

1 reference

12 August 2017

1 reference

12 August 2017

1 reference